Gerond Lake-Bakaar, MD; Winston Tom, MD; Desmond Lake-Bakaar, PhD; Neelam Gupta, MD; Sary Beidas, MD; Magdy Elsakr, MD; Eugene Straus, MD
Study Objective: To correlate oral ketoconazole absorption with gastric acid secretion in patients with the acquired immunodeficiency syndrome (AIDS).
Design: Prospective measurement of maximal acid output and oral ketoconazole absorption with and without 0. 1 -N hydrochloric acid.
Setting: Hospital in-patients in university medical center.
Patients: Ten consecutive male patients with AIDS.
Intervention: Maximal acid output was determined after pentagastrin stimulation in all patients. Serum ketoconazole levels were measured the day after ingestion of a 200-mg ketoconazole tablet in the fasted state. On the final day, ketoconazole was ingested with 200 mL of 0.1 -N hydrochloric acid.
Measurements and Main Results: Maximal acid output was below 15 mEq/h in 7 of 10 patients. In all 7, the area under the serum ketoconazole concentration —time curve was below normal (1.4 ± 0.9 mg/h • L; mean ± SE), and absorption was normalized by hydrochloric acid (9.9 ± mg/h • L). Two of three patients with maximal acid outputs above 15 mEq/h had normal ketoconazole absorption (15.1 ± 6.7 mg/h • L).
Conclusions: The bioavailability of oral ketoconazole is reduced in patients with AIDS, largely as a result of gastric hypochlorhydria. Ketoconazole tablets should therefore be given with acid in these patients.
Lake-Bakaar G, Tom W, Lake-Bakaar D, et al. Gastropathy and Ketoconazole Malabsorption in the Acquired Immunodeficiency Syndrome (AIDS). Ann Intern Med. 1988;109:471–473. doi: 10.7326/0003-4819-109-6-471
Download citation file:
Published: Ann Intern Med. 1988;109(6):471-473.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use